3-4516493-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001378452.1(ITPR1):āc.2T>Cā(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,407,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
ITPR1
NM_001378452.1 start_lost
NM_001378452.1 start_lost
Scores
8
7
1
Clinical Significance
Conservation
PhyloP100: 7.61
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPR1 | NM_001378452.1 | c.2T>C | p.Met1? | start_lost | 3/62 | ENST00000649015.2 | NP_001365381.1 | |
ITPR1 | NM_001168272.2 | c.2T>C | p.Met1? | start_lost | 3/61 | NP_001161744.1 | ||
ITPR1 | NM_001099952.4 | c.2T>C | p.Met1? | start_lost | 3/59 | NP_001093422.2 | ||
ITPR1 | NM_002222.7 | c.2T>C | p.Met1? | start_lost | 3/58 | NP_002213.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPR1 | ENST00000649015.2 | c.2T>C | p.Met1? | start_lost | 3/62 | NM_001378452.1 | ENSP00000497605 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1407762Hom.: 0 Cov.: 26 AF XY: 0.00000143 AC XY: 1AN XY: 700830
GnomAD4 exome
AF:
AC:
2
AN:
1407762
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
700830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 06, 2018 | This variant is expected to result in an absent or disrupted protein product. If translation initiation is rescued by the downstream methionine at codon 5, this would result in loss of first 4 amino acids from the N-terminal suppressor domain of the ITPR1 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with ITPR1-related disease. However, this variant has been observed to be de novo in an individual affected with clinical features of spinocerebellar ataxia type 29 (SCA29) (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change affects the initiator methionine of the ITPR1 mRNA. The next in-frame methionine is located at codon 5. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;.;.;.;D;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
N;N;N;N;N;N;N
PROVEAN
Uncertain
D;D;.;D;D;.;N;.;.;.;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;.;D;D;.;D;.;.;.;D
Sift4G
Pathogenic
D;D;.;.;D;.;D;.;.;.;D
Polyphen
0.72, 0.99
.;.;.;.;.;.;P;.;D;.;.
Vest4
MutPred
Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);Gain of phosphorylation at M1 (P = 0.022);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at